Detect, diagnose, and treat incurable diseases.
Affordable, non-invasive therapeutic with no known, serious side effects
Patented, cost-effective system with high ROI potential
Ready for commercialization. Experienced team seeking strategic partners
To view the full-length version of this video, please contact Anapole Technologies, Inc.
We aim to make the world a better place by bringing good health to all, so families and communities around the globe have more time to spend with their loved ones.
Our patient process is rapid and non-invasive. Our software and hardware platform allows for new diagnostics and treatments to be developed within months, not years, and at a relatively low cost.
Our devices are in their 6th generation, and clinical trials have shown effectiveness against HIV and pre-clinical success with tuberculosis and certain aggressive cancers.
“The possibility of repetitive therapy sessions using Resonance Generating Fields (RGFIELDS)™ has profound implications that may create valuable medical options and a paradigm shift in cancer therapy.”
— excerpt, published glioblastoma cell study
The solution is inherently more affordable than legacy medical treatments and provides a higher return on investment.
- Price points for treatment allow providers to reach a broader pool of patients.
- Advancements in treatments are backward-compatible to existing hardware installations.
- Treatments are far less time-consuming than legacy medical practices.
Continue the Conversation
Our team is excited to build towards the mission and vision of Anapole Technologies .